Previous Article | Next Article 
Applied and Environmental Microbiology, December 2007, p. 7799-7801, Vol. 73, No. 23
0099-2240/07/$08.00+0 doi:10.1128/AEM.01861-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Expression of Mycoplasma Proteins Carrying an Affinity Tag in M. pneumoniae Allows Rapid Purification and Circumvents Problems Related to the Aberrant Genetic Code
Sebastian R. Schmidl,
Claudine Hames, and
Jörg Stülke*
Department of General Microbiology, Institute of Microbiology and Genetics, Georg-August University Göttingen, Grisebachstr. 8, D-37077 Göttingen, Germany
Received 10 August 2007/
Accepted 2 October 2007

ABSTRACT
In
Mycoplasma pneumoniae and several other mollicutes, the UGA
opal codon specifies tryptophan rather than a translation stop.
This often makes it difficult to express
Mycoplasma proteins
in heterologous hosts. In this work, we demonstrate that mollicute
proteins can be fused to an affinity tag and be expressed directly
in
M. pneumoniae. The protein can then be purified by affinity
chromatography and be used for biochemical or any other desired
analysis.

INTRODUCTION
Mycoplasma pneumoniae is a human pathogen that thrives on mucosal
surfaces and causes diseases such as mild pneumonia, tracheobronchitis,
pediatric encephalitis, and erythema multiforme (
2,
11,
15,
18,
24). These bacteria possess one of the smallest genomes
of any free-living organism known so far. This reduced genome
has recently attracted much interest, as the analysis of
M. pneumoniae and its close relatives may help to identify the
minimal set of genes that is required for independent life (
4,
9). This prompted the development of the new field of synthetic
biology with projects aimed at the generation of artificial
microbes based on
Mycoplasma spp. (
3,
14). Another interesting
aspect of the small genome is the observation that several enzymes
of
Mycoplasma spp. are moonlighting: i.e., they have multiple
unrelated functions (
12). This was discovered for glycolytic
kinases that are also active as nucleoside diphosphate kinases
in
M. pneumoniae and other
Mycoplasma spp. (
17).
The analysis of proteins from Mycoplasma spp. is hampered by a peculiarity of the genetic code of these bacteria: they use the UGA opal codon to incorporate tryptophan rather than as a stop codon as in the universal genetic code (10, 19). Thus, if cloned in Escherichia coli or other hosts, the genes from M. pneumoniae often contain many stop codons that prevent heterologous expression. Several strategies have been developed to solve this problem. Expression of mollicute genes in Spiroplasma spp. that read the UGA as a tryptophan codon has been reported; however, these bacteria are difficult to handle (21). E. coli suppressor strains expressing an opal suppressor tRNA have been developed; however, they fail if multiple opal codons are present (20). M. pneumoniae genes containing few UGA codons have been expressed in Bacillus subtilis with low efficiency (13). Recently, we developed a PCR-based strategy to exchange as many as nine opal codons in a single step. This approach, the multiple mutation reaction, allowed the expression of the M. pneumoniae glycerol kinase and has been used for several other proteins (7). However, there are cases in which it is desirable to purify a mollicute protein from the original host. This is of special importance for protein-protein interaction studies. To facilitate gene expression and protein purification in M. pneumoniae, we developed a system for the expression of proteins fused to an N-terminal streptavidin (Strep) tag in M. pneumoniae. These proteins can easily be purified by affinity chromatography using Strep-tactin columns due to the highly specific interaction between the Strep-tag peptide and the artificial protein Strep-tactin (23).

Outline of the expression system.
To allow efficient expression and subsequent purification of
a protein of interest in
M. pneumoniae, the respective gene
has to be fused to an affinity tag and a promoter has to be
provided. We chose to use the Strep tag because this peptide
binds with high affinity to Strep-tactin materials and can be
eluted in a single step using desthiobiotin. In our hands, the
purification using the Strep tag is much more efficient than
the popular His tag for purification from both
E. coli and
B. subtilis (
8,
16). To drive the expression of the fusion proteins,
we selected a promoter fragment of the
M. pneumoniae ackA gene
encoding acetate kinase. This promoter was recently shown to
confer active transcription to a reporter gene in
M. pneumoniae (
6). Since there are no replicative plasmids for
M. pneumoniae available, we introduced the artificial gene by transposition
into the chromosome of
M. pneumoniae and assayed several clones
for expression of the recombinant protein using antibodies recognizing
the Strep tag.

Cloning of M. pneumoniae hprK and expression of the protein.
To test the anticipated expression system, we selected the
M. pneumoniae HPr kinase/phosphorylase (HPrK; encoded by the
hprK gene). We previously expressed HPrK with an N-terminal Strep
tag and demonstrated biochemical activity of the fusion protein
(
16). Plasmid pGP1012 allowing the expression of HPrK carrying
an N-terminal Strep tag under the control of the
ackA promoter
was constructed as follows. The DNA fragment corresponding to
the
hprK gene with a sequence specifying the Strep tag II at
its 5' end was amplified from plasmid pGP611 (
16) using the
oligonucleotides SS22 (5' AAACTGCAGTGGAGCCACCCGCAGTTCG) and
SS23 (5' AAAGCGGCCGCGGTCTGCTACTAACACTAGGATTCATC). In addition,
the
ackA promoter fragment, which also contains the Shine-Dalgarno
sequence and the ATG start codon of the acetate kinase open
reading frame, was amplified from
M. pneumoniae chromosomal
DNA using the primer pair SH58 (
6) and SS21 (5' AAACTGCAGCATTTTTATCTAATAGGTAACAA).
The promoter and the
hprK gene fragments were digested with
EcoRI/PstI and PstI/NotI, respectively, and ligated to pMT85
(
25) linearized with EcoRI and NotI in a three-fragment ligation
mixture. The correctness of the resulting plasmid, pGP1012,
was verified by restriction and sequence analysis. Plasmid pMT85
(and thus, pGP1012) carries an
aac-aphD gentamicin resistance
determinant as well as a derivative of Tn
4001 that lacks the
transposase gene (mini-Tn
4001) to avoid transposition after
the initial integration into the
M. pneumoniae chromosome. The
tranposase gene is located on the plasmid backbone that is lost
upon transposition (
25). This allows the random integration
of the cassette carrying the
ackA promoter and the artificial
strep-hprK gene in the chromosome of
M. pneumoniae. For this
purpose, we introduced pGP1012 (and as a control, pMT85) by
electroporation into
M. pneumoniae M129 as described earlier
(
1). Transformants were selected on plates containing gentamicin.
To check the expression of the tagged HPrK in the transformants, we cultivated five independent clones obtained with pGP1012 and one transformant carrying the empty mini-Tn4001 derived from pMT85 and prepared cell extracts. These cell extracts were separated by one-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and the proteins were transferred to a polyvinylidene difluoride membrane by electroblotting. The presence of Strep-HPrK was verified using polyclonal antibodies directed against Strep-glycerol kinase (GlpK) from M. pneumoniae (SeqLab, Göttingen, Germany). We observed that these antibodies were able to efficiently cross-react with the Strep tag in addition to M. pneumoniae GlpK (data not shown). As shown in Fig. 1, a Strep-tagged protein corresponding in size exactly to the Strep-HPrK purified from E. coli was present in all clones carrying the minitransposon derived from pGP1012 but not in those carrying the empty mini-Tn4001 (pMT85). Since the minitransposon can be inserted at a different position in each clone, we cannot exclude position effects on the expression of the construct. Based on the Western blot shown in Fig. 1, we selected clone 1 for the purification of Strep-HPrK. This strain was designated GPM78.

Purification of Strep-HPrK and activity assay.
To purify the tagged HPrK, we cultivated
M. pneumoniae GPM78
in 400 ml of modified Hayflick medium (
5). The cells were disrupted
by sonication, and the cell extracts were passed over a Strep-tactin
Sepharose column (IBA GmbH, Göttingen, Germany). After
five washing steps, the protein carrying a Strep tag was eluted
by applying desthiobiotin (2.5 mM) to the columns as described
previously (
16). The purified protein was further analyzed by
SDS-PAGE (Fig.
2). Using this procedure, we obtained 25 µg
of virtually pure protein from a culture of 400 ml (concentration,
100 ng/µl).
The purified Strep-HPrK was used for activity assays: i.e.,
the phosphorylation of
M. pneumoniae HPr protein at the expense
of ATP. For this purpose, we purified HPr carrying an N-terminal
His tag using
E. coli DH5

/pGP217 (
22). The activity assays were
performed as described previously (
22). As shown in Fig.
3,
the Strep-HPrK purified from
M. pneumoniae was active in the
phosphorylation of HPr.
This study demonstrates that the purification of Strep-tagged
proteins directly from
M. pneumoniae is an alternative to their
expression in heterologous hosts such as
E. coli, which often
requires the laborious replacement of opal codons to prevent
premature translation termination. We are confident that other
Mycoplasma species such as
M. genitalium might also be used
as expression hosts. Moreover, the application of novel, potentially
stronger promoters and translation signals may increase the
efficiency of protein expression. The proteins isolated in this
way can be used for biochemical characterization or for the
generation of antibodies. Moreover, the expression in
M. pneumoniae also allows the isolation of functional protein complexes (
8;
our unpublished results).

ACKNOWLEDGMENTS
We are grateful to Richard Herrmann for the generous gift of
plasmid pMT85 and to Julia Busse for excellent technical assistance.
This work was supported by the Deutsche Forschungsgemeinschaft and the Fonds der Chemischen Industrie.

FOOTNOTES
* Corresponding author. Mailing address: Department of General Microbiology, Institute of Microbiology and Genetics, Georg-August University Göttingen, Grisebachstr. 8, D-37077 Göttingen, Germany. Phone: 49-551-393781. Fax: 49-551-393808. E-mail:
jstuelk{at}gwdg.de 
Published ahead of print on 12 October 2007. 

REFERENCES
1 - Catrein, I., R. Dumke, J. Weiner III, E. Jacobs, and R. Herrmann. 2004. Cross-complementation between the products of the genes P1 and ORF6 of Mycoplasma pneumoniae subtypes 1 and 2. Microbiology 150:3989-4000.[Abstract/Free Full Text]
2 - Christie, L. J., S. Honarmand, D. F. Talkington, S. S. Gavali, C. Preas, C. Y. Pan, S. Yagi, and C. A. Glaser. 2007. Pediatric encephalitis: what is the role of Mycoplasma pneumoniae? Pediatrics 120:305-313.[Abstract/Free Full Text]
3 - Drubin, D. A., J. C. Way, and P. A. Silver. 2007. Designing biological systems. Genes Dev. 21:242-254.[Abstract/Free Full Text]
4 - Glass, J. I., N. Assad-Garcia, N. Alperovich, S. Yooseph, M. R. Lewis, M. Maruf, C. A. Hutchison III, H. O. Smith, and J. C. Venter. 2006. Essential genes of a minimal bacterium. Proc. Natl. Acad. Sci. USA 103:425-430.[Abstract/Free Full Text]
5 - Halbedel, S., C. Hames, and J. Stülke. 2004. In vivo activity of enzymatic and regulatory components of the phosphoenolpyruvate:sugar phosphotransferase system in Mycoplasma pneumoniae. J. Bacteriol. 186:7936-7943.[Abstract/Free Full Text]
6 - Halbedel, S., H. Eilers, B. Jonas, J. Busse, M. Hecker, S. Engelmann, and J. Stülke. 2007. Transcription in Mycoplasma pneumoniae: analysis of the promoters of the ackA and ldh genes. J. Mol. Biol. 371:596-607.[CrossRef][Medline]
7 - Hames, C., S. Halbedel, O. Schilling, and J. Stülke. 2005. Multiple-mutation reaction: a method for the simultaneous introduction of multiple mutations into the glpK gene of Mycoplasma pneumoniae. Appl. Environ. Microbiol. 71:4097-4100.[Abstract/Free Full Text]
8 - Herzberg, C., L. A. Flórez Weidinger, B. Dörrbecker, S. Hübner, J. Stülke, and F. M. Commichau. SPINE: a method for the rapid detection and analysis of protein-protein interactions in vivo. Proteomics, in press.
9 - Hutchison, C. A., III, S. C. Peterson, S. R. Gill, R. T. Cline, O. White, C. M. Fraser, H. O. Smith, and J. C. Venter. 1999. Global transposon mutagenesis and a minimal mycoplasma genome. Science 286:2165-2169.[Abstract/Free Full Text]
10 - Inamine, J. M., K.-C. Ho, S. Loechel, and P.-C. Hu. 1990. Evidence that UGA is read as a tryptophan codon rather than as a stop codon by Mycoplasma pneumoniae, Mycoplasma genitalium, and Mycoplasma gallisepticum. J. Bacteriol. 172:504-506.[Abstract/Free Full Text]
11 - Jacobs, E. 1997. Mycoplasma infections of the human respiratory tract. Wien. Klin. Wochenschr. 109:574-577.[Medline]
12 - Jeffery, C. J. 2003. Moonlighting proteins: old proteins learning new tricks. Trends Genet. 19:415-417.[CrossRef][Medline]
13 - Kannan, T. R., and J. B. Baseman. 2000. Expression of UGA-containing Mycoplasma genes in Bacillus subtilis. J. Bacteriol. 182:2664-2667.[Abstract/Free Full Text]
14 - Lartigue, C., J. I. Glass, N. Alperovich, R. Pieper, P. P. Parmar, C. A. Hutchison III, H. O. Smith, and J. C. Venter. 2007. Genome transplantation in bacteria: changing one species to another. Science 317:632-638.[Abstract/Free Full Text]
15 - Lind, K. 1983. Manifestations and complications of Mycoplasma pneumoniae disease: a review. Yale J. Biol. Med. 56:461-468.[Medline]
16 - Merzbacher, M., C. Detsch, W. Hillen, and J. Stülke. 2004. Mycoplasma pneumoniae HPr kinase/phosphorylase. Assigning functional roles to the P-loop and the HPr kinase/phosphorylase signature sequence motif. Eur. J. Biochem. 271:367-374.[Medline]
17 - Pollack, J. D., M. A. Myers, T. Dandekar, and R. Herrmann. 2002. Suspected utility of enzymes with multiple activities in the small genome Mycoplasma species: the replacement of the missing "household" nucleoside diphosphate kinase gene and activity by glycolytic kinases. OMICS J. Integr. Biol. 6:247-257.[CrossRef]
18 - Schalock, P. C., J. G. Dinulos, N. Pace, K. Schwarzenberger, and J. K. Wenger. 2006. Erythema multiforme due to Mycoplasma pneumoniae infection in two children. Pediatr. Dermatol. 23:546-555.[CrossRef][Medline]
19 - Simoneau, P., C.-M. Li, S. Loechel, R. Wenzel, R. Herrmann, and P.-C. Hu. 1993. Codon reading scheme in Mycoplasma pneumoniae revealed by the analysis of the complete set of tRNA genes. Nucleic Acids Res. 21:4967-4974.[Abstract/Free Full Text]
20 - Smiley, B. K., and F. C. Minion. 1993. Enhanced readthrough of opal (UGA) stop codons and production of Mycoplasma pneumoniae P1 epitopes in Escherichia coli. Gene 134:33-40.[CrossRef][Medline]
21 - Stamburski, C., J. Renaudin, and J. M. Bove. 1991. First steps toward a virus-derived vector for gene cloning and expression in spiroplasmas, organisms which read UGA as a tryptophan codon: synthesis of chloramphenicol acetyltransferase in Spiroplasma citri. J. Bacteriol. 173:2225-2230.[Abstract/Free Full Text]
22 - Steinhauer, K., T. Jepp, W. Hillen, and J. Stülke. 2002. A novel mode of control of Mycoplasma pneumoniae HPr kinase/phosphatase activity reflects its parasitic life style. Microbiology 148:3277-3284.[Abstract/Free Full Text]
23 - Terpe, K. 2006. Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems. Appl. Microbiol. Technol. 72:211-222.[CrossRef][Medline]
24 - Waites, K. B., and D. F. Talkington. 2004. Mycoplasma pneumoniae and its role as a human pathogen. Clin. Microbiol. Rev. 17:697-728.[Abstract/Free Full Text]
25 - Zimmerman, C.-U., and R. Herrmann. 2005. Synthesis of a small, cysteine-rich, 29 amino acids long peptide in Mycoplasma pneumoniae. FEMS Microbiol. Lett. 253:315-321.[CrossRef][Medline]
Applied and Environmental Microbiology, December 2007, p. 7799-7801, Vol. 73, No. 23
0099-2240/07/$08.00+0 doi:10.1128/AEM.01861-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.